Watch Point Trust Co Lowers stake in Stryker Corporation (SYK)

Stryker Corporation (SYK) : Watch Point Trust Co reduced its stake in Stryker Corporation by 1.1% during the most recent quarter end. The investment management company now holds a total of 34,725 shares of Stryker Corporation which is valued at $3,798,915 after selling 385 shares in Stryker Corporation , the firm said in a disclosure report filed with the SEC on Apr 20, 2016.Stryker Corporation makes up approximately 3.33% of Watch Point Trust Co’s portfolio.

Stryker Corporation opened for trading at $109.44 and hit $110.06 on the upside on Friday, eventually ending the session at $109.4, with a gain of 0.08% or 0.09 points. The heightened volatility saw the trading volume jump to 18,37,756 shares. Company has a market cap of $40,804 M.

Other Hedge Funds, Including , Butensky Cohen Financial Security Inc sold out all of its stake in SYK during the most recent quarter. The investment firm sold 31 shares of SYK which is valued $3,391.Taylor Wealth Management Partners boosted its stake in SYK in the latest quarter, The investment management firm added 550 additional shares and now holds a total of 750 shares of Stryker Corporation which is valued at $82,350. Stryker Corporation makes up approx 0.04% of Taylor Wealth Management Partners’s portfolio.Exxonmobil Investment Management Inc Tx boosted its stake in SYK in the latest quarter, The investment management firm added 5,489 additional shares and now holds a total of 76,282 shares of Stryker Corporation which is valued at $8,375,764. Stryker Corporation makes up approx 0.19% of Exxonmobil Investment Management Inc Tx’s portfolio.Jlb Associates Inc reduced its stake in SYK by selling 251 shares or 0.56% in the most recent quarter. The Hedge Fund company now holds 44,804 shares of SYK which is valued at $4,850,033. Stryker Corporation makes up approx 1.43% of Jlb Associates Inc’s portfolio.

On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.

Many Wall Street Analysts have commented on Stryker Corporation. Company shares were Reiterated by RBC Capital Mkts on Apr 26, 2016 to “Outperform”, Firm has raised the Price Target to $ 120 from a previous price target of $108 .Company shares were Downgraded by Robert W. Baird on Apr 13, 2016 to ” Neutral”, Firm has raised the Price Target to $ 116 from a previous price target of $111 .Barclays Resumed Stryker Corporation on Apr 11, 2016 to “Underweight”, Price Target of the shares are set at $107.

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.

Leave a Reply

Stryker Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Stryker Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.